Serretti, Alessandro.
Alessandro Serretti researcher
VIAF ID: 46150868217822071111 (Personal)
Permalink: http://viaf.org/viaf/46150868217822071111
Preferred Forms
- 100 0 _ ‡a Alessandro Serretti ‡c researcher
-
- 100 1 _ ‡a Serretti, Alessandro
-
- 100 1 _ ‡a Serretti, Alessandro
-
- 100 1 _ ‡a Serretti, Alessandro
- 100 1 _ ‡a Serretti, Alessandro
-
-
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Acute antipyschotic efficacy and side effects in schizophrenia : association with serotonin transporter promoter genotypes | |
Adenosine hypothesis of antipsychotic drugs revisited : pharmacogenomics variation in nonacute schizophrenia | |
Akutna učinkovitost antipsihotične terapije in neželeni učinki pri shizofreniji: povezava z genotipi za serotoninski prenašalec (transporter) | |
Dried volumetric microsampling approaches for the therapeutic drug monitoring of psychiatric patients undergoing clozapine treatment | |
Fine-mapping genomic loci refines bipolar disorder risk genes | |
Genetic influences and alcohol dependence in Slovenian population | |
Genetic influences on response to drug treatment for major psychiatric disorders, 2016: | |
Genetic variability in CYP2E1 and catalase gene among currently and formerly alcohol-dependent male subjects | |
Genetyka i farmakogenetyka zaburzeń nastroju = Genetics and pharmacogenetics of mood disorders | |
MDR1 gene polymorphisms and response to acute risperidone treatment | |
Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls | |
Oxidative stress and expression of alcohol related psychopathological symptoms in alcohol dependent subjects | |
Pharmacogenetics of antidepressants = Farmakogenetika antidepresivov | |
Polymorphisms in dopamine receptor DRD1 and DRD2 genes and psychopathological and extrapyramidal symptoms in patients on long-term antipsychotic treatment | |
The Present and Future of Precision Medicine in Psychiatry | |
Self-harm in prisoners | |
Serotonin Transporter Gene (5-HTTLPR) Polymorphism and Efficacy of Selective Serotonin Reuptake Inhibitors : Do We Have Sufficient Evidence for Clinical Practice |